RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci.

Journal Article (Journal Article)

To assess the potential clinical utility of RP 59500, 10 investigators from separate locations in the United States and Canada each tested approximately 200 current isolates of staphylococci (Staphylococcus aureus and coagulase-negative staphylococci) by a standard protocol. RP 59500 was highly active (MIC90 < or = 2 micrograms/ml) against all strains, including those that were resistant to oxacillin, ciprofloxacin, erythromycin, and spiramycin.

Full Text

Duke Authors

Cited Authors

  • Archer, GL; Auger, P; Doern, GV; Ferraro, MJ; Fuchs, PC; Jorgensen, JH; Low, DE; Murray, PR; Reller, LB; Stratton, CW

Published Date

  • March 1, 1993

Published In

Volume / Issue

  • 16 / 3

Start / End Page

  • 223 - 226

PubMed ID

  • 8477576

International Standard Serial Number (ISSN)

  • 0732-8893

Digital Object Identifier (DOI)

  • 10.1016/0732-8893(93)90113-l


  • eng

Conference Location

  • United States